Summit Partners Public Asset Management, LLC United Therapeutics Corp Transaction History

Summit Partners Public Asset Management, LLC

$2.79 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $7.6 Million - $10.3 Million	36,878 New	36,878 $10.3 Million
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $22.2 Million - $28.6 Million	-133,592 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$184.32 - $216.08 $24.6 Million - $28.9 Million	133,592 New	133,592 $28.9 Million

Others Institutions Holding UTHR

# of Institutions

669

Shares Held

42.8M

Call Options Held

194K

Put Options Held

295K

Black Rock Inc. New York, NY

5.47M
Shares

$2.04 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

4.41M
Shares

$1.64 Billion
0.03% of portfolio
Wellington Management Group LLP Boston, MA

3.17M
Shares

$1.18 Billion
0.2% of portfolio
Avoro Capital Advisors LLC New York, NY

2.86M
Shares

$1.07 Billion
15.42% of portfolio
State Street Corp Boston, MA

2.24M
Shares

$835 Million
0.03% of portfolio

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.

Account